Trial Profile
A randomised control study investigating effectiveness of single dose of Eptifibatide in patients with non-ST elevated Myocardial Infarction (NSTEMI) underwent Percutaneous Coronary Intervention (PCI)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2016
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary) ; Aspirin; Clopidogrel
- Indications Myocardial infarction
- Focus Therapeutic Use
- 20 Sep 2016 New trial record